Literature DB >> 19959985

Global measles mortality, 2000-2008.

.   

Abstract

The United Nations (UN) Millennium Development Goals include a goal (MDG 4) to achieve a two thirds overall reduction of child deaths by 2015 compared with the 1990 level. Because many unvaccinated children die from measles, routine measles vaccination coverage is used as an indicator of progress toward this goal. In 2008, all UN member states reaffirmed their commitment to achieving a 90% reduction in measles mortality by 2010 compared with 2000, from an estimated 733,000 deaths in 2000 worldwide to <73,300 by 2010. The World Health Organization (WHO) and UNICEF have identified 47 priority countries with the highest burden of measles for an accelerated strategy for measles mortality reduction. The strategy includes 1) achieving and maintaining high coverage (>or=90% nationally and >or=80% in each district) with 2 doses of measles-containing vaccine (MCV) delivered through routine services or supplemental immunization activities (SIAs) , 2) implementing effective laboratory-supported disease surveillance, and 3) providing appropriate clinical management for measles cases. This report updates a previously published report, provides details on activities implemented during 2008, assesses progress toward the 2010 goal, and evaluates the potential effects of decreased financial support. During 2000--2008, global measles mortality declined by 78%, from an estimated 733,000 deaths in 2000 to 164,000 in 2008, but the reduction in measles mortality has been leveling off since 2007. To reach the 2010 goal, India should fully implement the recommended strategies, and financial support for sustaining measles control in the other 46 priority countries should be secured.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19959985

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  28 in total

1.  Independence of measles-specific humoral and cellular immune responses to vaccination.

Authors:  Robert M Jacobson; Inna G Ovsyannikova; Robert A Vierkant; V Shane Pankratz; Gregory A Poland
Journal:  Hum Immunol       Date:  2012-03-03       Impact factor: 2.850

2.  Atypical measles syndrome in adults: still around.

Authors:  Cléa Melenotte; Nadim Cassir; Laurent Tessonnier; Philippe Brouqui
Journal:  BMJ Case Rep       Date:  2015-09-23

3.  Successful respiratory immunization with dry powder live-attenuated measles virus vaccine in rhesus macaques.

Authors:  Wen-Hsuan Lin; Diane E Griffin; Paul A Rota; Mark Papania; Stephen P Cape; David Bennett; Brian Quinn; Robert E Sievers; Charles Shermer; Kenneth Powell; Robert J Adams; Steven Godin; Scott Winston
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-31       Impact factor: 11.205

Review 4.  Measles virus, immune control, and persistence.

Authors:  Diane E Griffin; Wen-Hsuan Lin; Chien-Hsiung Pan
Journal:  FEMS Microbiol Rev       Date:  2012-03-13       Impact factor: 16.408

5.  Letter to the editor: Fatal varicella due to the vaccine-strain varicella-zoster virus.

Authors:  Emily Jane Woo
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

6.  Increasing the time of exposure to aerosol measles vaccine elicits an immune response equivalent to that seen in 9-month-old Mexican children given the same dose subcutaneously.

Authors:  Rosa María Wong-Chew; Miguel Leonardo García-León; Bogart Espinosa-Torres Torrija; Brenda Hernández-Pérez; Lino E Cardiel-Marmolejo; Judy A Beeler; Susette Audet; José Ignacio Santos-Preciado
Journal:  J Infect Dis       Date:  2011-08-01       Impact factor: 5.226

7.  Enhancing the work of the Department of Health and Human Services national vaccine program in global immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on September 12, 2013.

Authors: 
Journal:  Public Health Rep       Date:  2014       Impact factor: 2.792

8.  The effects of weather conditions on measles incidence in Guangzhou, Southern China.

Authors:  Qiongying Yang; Chuanxi Fu; Zhiqiang Dong; Wensui Hu; Ming Wang
Journal:  Hum Vaccin Immunother       Date:  2014-02-06       Impact factor: 3.452

9.  Genetic characterization of wild-type measles viruses isolated in China, 2006-2007.

Authors:  Yixin Ji; Songtao Xu; Yan Zhang; Zhen Zhu; Naiying Mao; Xiaohong Jiang; Chao Ma; Peishan Lu; Changyin Wang; Yong Liang; Huanying Zheng; Yang Liu; Defang Dai; Lei Zheng; Jianhui Zhou; Shuang Wang; Zhenying Zhang; Shengwei Wu; Lijuan Nan; Li Li; Xiaofeng Liang; David Alexander Featherstone; Paul A Rota; William J Bellini; Wenbo Xu
Journal:  Virol J       Date:  2010-05-25       Impact factor: 4.099

10.  Identifying high-risk areas for sporadic measles outbreaks: lessons from South Africa.

Authors:  Benn Sartorius; C Cohen; T Chirwa; G Ntshoe; A Puren; K Hofman
Journal:  Bull World Health Organ       Date:  2013-01-11       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.